ES2057441T3 - Derivados de piridina, procesos para su preparacion y composiciones farmaceuticas de los mismos. - Google Patents

Derivados de piridina, procesos para su preparacion y composiciones farmaceuticas de los mismos.

Info

Publication number
ES2057441T3
ES2057441T3 ES90312167T ES90312167T ES2057441T3 ES 2057441 T3 ES2057441 T3 ES 2057441T3 ES 90312167 T ES90312167 T ES 90312167T ES 90312167 T ES90312167 T ES 90312167T ES 2057441 T3 ES2057441 T3 ES 2057441T3
Authority
ES
Spain
Prior art keywords
piridine
derivatives
preparation
processes
pharmaceutical compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90312167T
Other languages
English (en)
Inventor
Gyorgy Dr Domany
Elemer Ezer
Istvan Dr Schon
Judit Dr Matuz
Katalin Dr Saghy
Laszlo Dr Szporny
Gyorgy Dr Hajos
Marta Renyet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Richter Gedeon Vegyeszeti Gyar Nyrt
Original Assignee
Richter Gedeon Vegyeszeti Gyar RT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszeti Gyar RT filed Critical Richter Gedeon Vegyeszeti Gyar RT
Application granted granted Critical
Publication of ES2057441T3 publication Critical patent/ES2057441T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/76—Nitrogen atoms to which a second hetero atom is attached
    • C07D213/77—Hydrazine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

LA INVENCION SE REFIERE A LOS DERIVADOS DE LA PIRIDINA DE LA FORMULA (I): DONDE Q REPRESENTA UN GRUPO NITRO O CIANO; Y X ELEVADO 1 Y X (AL CUADRADO) , QUE PUEDEN SER LOS MISMOS O DISTINTOS, REPRESENTAN UN ATOMO DE HIDROGENO O DE HALOGENO, O UN GRUPO DE TRIFLUOROMETIL, DE UN ALCALI BAJO, DE ALKOXI O DE NITRO, UNIDOS A CUALQUIERA DE LOS ATOMOS DE CARBONO DEL ANILLO DE FENILO. LA INVENCION TAMBIEN SE REFIERE A LOS COMPUESTOS FARMACEUTICOS QUE CONTIENEN ESTA COMPOSICION Y A LOS PROCEDIMIENTOS PARA SU PREPARACION. LOS COMPUESTOS DE LA FORMULA (I) GOZAN DE INHIBICION A LAS SECRECIONES DE ACIDO GASTRICO, DE PROTECCION DE LOS TEJIDOS, DE EFECTOS ANALGESICOS Y ANTIINFLAMATORIOS SUAVES Y SON UTILES A EFECTOS TERAPEUTICOS.
ES90312167T 1989-11-07 1990-11-07 Derivados de piridina, procesos para su preparacion y composiciones farmaceuticas de los mismos. Expired - Lifetime ES2057441T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU895807A HU207047B (en) 1989-11-07 1989-11-07 Process for producing new pyridine derivatives and pharmaceutical copositions comprising same

Publications (1)

Publication Number Publication Date
ES2057441T3 true ES2057441T3 (es) 1994-10-16

Family

ID=10970765

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90312167T Expired - Lifetime ES2057441T3 (es) 1989-11-07 1990-11-07 Derivados de piridina, procesos para su preparacion y composiciones farmaceuticas de los mismos.

Country Status (20)

Country Link
US (1) US5155123A (es)
EP (1) EP0427526B1 (es)
JP (1) JPH03169862A (es)
KR (1) KR910009663A (es)
CN (1) CN1052305A (es)
AR (1) AR248394A1 (es)
AT (1) ATE109137T1 (es)
AU (1) AU631261B2 (es)
CA (1) CA2029222A1 (es)
DE (1) DE69011046T2 (es)
DK (1) DK0427526T3 (es)
ES (1) ES2057441T3 (es)
FI (1) FI905493A0 (es)
HU (1) HU207047B (es)
IL (1) IL96252A (es)
IN (1) IN171700B (es)
NO (1) NO177263C (es)
NZ (1) NZ235984A (es)
PH (1) PH27440A (es)
ZA (1) ZA908889B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1035115B1 (en) 1999-02-24 2004-09-29 F. Hoffmann-La Roche Ag 4-Phenylpyridine derivatives and their use as NK-1 receptor antagonists
TWI280239B (en) 2003-07-15 2007-05-01 Hoffmann La Roche Process for preparation of pyridine derivatives
CN101267808A (zh) 2005-09-23 2008-09-17 弗·哈夫曼-拉罗切有限公司 新型制剂
EP2628389A4 (en) * 2010-08-31 2014-01-01 Meiji Seika Pharma Co Ltd AGENT FOR COMBATING HARMFUL ORGANISMS
BR112014004268A8 (pt) * 2011-08-26 2023-01-17 Meiji Seika Pharma Co Ltd método para a produção de agente de controle de praga
US20210238176A1 (en) 2018-08-07 2021-08-05 Syngenta Crop Protection Ag Pesticidally-active bicyclic heteroaromatic compounds
AR117291A1 (es) 2018-12-14 2021-07-28 Syngenta Crop Protection Ag Compuestos heterocíclicos de cianamida con actividad pesticida
WO2020169526A1 (en) 2019-02-18 2020-08-27 Syngenta Crop Protection Ag Pesticidally-active cyanamide heterocyclic compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1201119A (en) * 1978-09-18 1986-02-25 Mcneilab, Inc. Diaza-cyclic derivatives of guanidine
HU188852B (en) * 1983-03-16 1986-05-28 Richter Gedeon Vegyeszeti Gyar Rt,Hu Process for producing thiazolidine derivatives active against gastric ulcer and intestinal ulcer
JPH07121909B2 (ja) * 1986-09-10 1995-12-25 日本バイエルアグロケム株式会社 新規複素環式化合物及び殺虫剤

Also Published As

Publication number Publication date
NO177263C (no) 1995-08-16
IN171700B (es) 1992-12-12
DE69011046D1 (de) 1994-09-01
AU6582390A (en) 1991-05-23
CA2029222A1 (en) 1991-05-08
JPH03169862A (ja) 1991-07-23
AU631261B2 (en) 1992-11-19
NZ235984A (en) 1992-08-26
ZA908889B (en) 1991-10-30
HU207047B (en) 1993-03-01
IL96252A (en) 1994-12-29
CN1052305A (zh) 1991-06-19
HU895807D0 (en) 1990-01-28
AR248394A1 (es) 1995-08-18
PH27440A (en) 1993-07-02
NO904822D0 (no) 1990-11-06
DE69011046T2 (de) 1994-11-24
EP0427526A1 (en) 1991-05-15
KR910009663A (ko) 1991-06-28
FI905493A0 (fi) 1990-11-06
EP0427526B1 (en) 1994-07-27
US5155123A (en) 1992-10-13
NO904822L (no) 1991-05-08
ATE109137T1 (de) 1994-08-15
NO177263B (no) 1995-05-08
HUT55758A (en) 1991-06-28
DK0427526T3 (da) 1994-08-29
IL96252A0 (en) 1991-08-16

Similar Documents

Publication Publication Date Title
ES2094721T3 (es) Analogos de la camptotecina solubles en agua.
PT89110A (pt) Processo de preparacao de derivados da quinazolina e de composicoes farmaceuticas que os contem
DK363689D0 (da) Purinonderivater og fremgangsmaade til fremstilling deraf
MX9203550A (es) Derivados de 4-aminoquinolina y su uso como medicamentos.
IL114537A0 (en) Sulfonamide derivatives of azolones their preparation and pharmaceutical compositions containing them
ES2052603T3 (es) Derivados de bencimidazol, procedimiento para su produccion y composicion farmaceutica que los contienen.
ES2038630T3 (es) Un procedimiento para preparar un compuesto de acido fenoxiacetico.
ES2038172T3 (es) Procedimiento para preparar carboxamidas heterociclicas.
AR002711A1 (es) Un compuesto de 2-carboxindol-3-substituido,un proceso para su preparacion, un nuevo compuesto intermediario para dicho proceso, el uso del compuesto parala fabricacion de un agente terapeutico y una composicion farmaceutica que comprende dicho compuesto.
ES2057441T3 (es) Derivados de piridina, procesos para su preparacion y composiciones farmaceuticas de los mismos.
ES2074492T3 (es) Derivados de acidos biliares, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
PT89788A (pt) Processo de preparacao de derivados da quinolina substituidas e de composicoes farmaceuticas que os contem
ES2188743T3 (es) Compuestos de acido pirrolidinilhidroxamico y procedimiento de produccion de los mismos.
SE9000871D0 (sv) Derivatives of thieno-triazolo-diazepine, a preparation process of the same and therapeutic compositions containing them
ES2056073T3 (es) Aril-aralquil-eteres, procedimientos para su preparacion y composicion farmaceutica que los comprende.
ES2032752T3 (es) Procedimiento de preparacion de derivados de la 1-bencenosulfonil-2-oxo-5-alcoxi-pirrolidina.
ES524961A0 (es) Procedimiento para la obtencion de esteres fenolicos
IL79910A (en) 5,7-dihydro-6-(thi)oxopyrrolo(2,3-f)benzimidazole,-benzothiazole and-benzoxazoles,6-imines thereof,their preparation and pharmaceutical compositions containing them
ES2069719T3 (es) Nuevos derivados de tiofeno, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES2070522T3 (es) Compuestos anti-inflamatorios.
IT1197516B (it) Derivati teofillinmetilanici e teofillinmetilditianici procedimento per la loro preparazione e composizioni farmaceutiche che li comprendono
CU23155A3 (es) DERIVADOS DEL áCIDO OCTAHIDRO-6, 10-DIOXO-6H-PIRIDAZINO(1,2-A)(1,2) DIAZEPIN-1-CARBOXILICO, SU PROCEDIMIENTO DE PREPARACION Y SU APLICACION PARA LA PREPARACION DE COMPUESTOS TERAPéUTICAMENTE ACTIVOS
ES8802612A1 (es) Procedimiento para preparar derivados de benzisoselenazolilo
AR008245A1 (es) Derivados de acido acetico, uso de los mismos en la fabricacion de un agente terapeutico y proceso para preparar dichos derivados
ES2036545T3 (es) Derivados de n-1h-tetrazol-5-il-(anillo de 5 eslabones)-carboxamida, un procedimiento para su preparacion y el uso de los mismos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 427526

Country of ref document: ES